Is the Etoposide, Doxorubicin, and Cisplatin Plus Mitotane Regimen Able to Prolong Survival in Patients With Metastatic Adrenocortical Carcinoma?

Endocrine Practice · Elsevier

Аннотация

Publication date: October 2026 Source: Endocrine Practice, Volume 32, Issue 10 Author(s): Alfredo Berruti, Deborah Cosentini, Marta Laganà, Salvatore Grisanti

Читать у издателя →

Похожие статьи